|
MEX3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.375350E-04 |
| Normal-vs-Stage3 |
2.30115926314056E-12 |
| Normal-vs-Stage4 |
4.240600E-04 |
| Stage1-vs-Stage2 |
7.642700E-03 |
| Stage1-vs-Stage3 |
4.680400E-01 |
| Stage1-vs-Stage4 |
4.993600E-01 |
| Stage2-vs-Stage3 |
6.899700E-02 |
| Stage2-vs-Stage4 |
5.901700E-02 |
| Stage3-vs-Stage4 |
3.306800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.715900E-02 |
| Normal-vs-Asian |
9.93070000010476E-07 |
| Caucasian-vs-AfricanAmerican |
4.748200E-01 |
| Caucasian-vs-Asian |
3.682400E-01 |
| AfricanAmerican-vs-Asian |
3.460000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
7.379000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.08562073062058E-14 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.8521899999957E-05 |
| Normal-vs-Age(81-100Yrs) |
1.277990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.352400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.572800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.945400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.953600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.478800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.466000E-01 |
| Classical-VS-Follicular |
1.98455000000042E-05 |
| Classical-VS-Other |
7.154800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
3.117700E-03 |
| Tall-VS-Other |
6.071800E-01 |
| Tall-VS-Normal |
1.82289999983709E-07 |
| Follicular-VS-Other |
7.037800E-02 |
| Follicular-VS-Normal |
1.123800E-01 |
| Other-VS-Normal |
1.173980E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22044604925031E-15 |
| Normal-vs-N1 |
8.41690000000783E-05 |
| N0-vs-N1 |
8.464300E-02 |
|
|
